Genmab | Profitto Lordo Sulle Vendite



Gross Profit On Sales Cambiamento Data
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
Almirall EUR 377.39M 145.71M 2024-12
Amarin USD 16.28M 26.49M 2024-09
Amgen USD 5.54B 430M 2025-03
argenx SE USD 709.88M 44.12M 2025-03
AstraZeneca USD 11.35B 819M 2025-03
Bayer EUR 8.11B 2.11B 2025-03
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Demant DKK 8.58B 4.32B 2024-12
Exelixis USD 536.28M 10.51M 2025-04
Fresenius Medical Care EUR 1.18B 86.43M 2025-03
Galapagos EUR 61.25M 98.68M 2025-03
Genmab DKK 673M 5.43B 2025-03
GlaxoSmithKline GBP 5.59B 34M 2025-03
GN Store Nord DKK 2.19B 482M 2025-03
GRIFOLS EUR 694.67M 71.83M 2025-03
Hikma Pharmaceutical USD 756M 82M 2024-06
Insmed USD 71.54M 6.75M 2025-03
Lonza CHF 1.12B 276M 2024-06
Merck EUR 3.1B 45M 2024-12
Novartis USD 10.23B 294M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
UCB EUR 970M 788M 2024-06



Genmab Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.